Cancer tops Bupa CI claims

clock

The majority of critical illness claims are related to cancer, according to Bupa Individual Protection.

The company’s claim statistics reveal over half (55%) of critical illness (CI) claims are related to cancer and more women than men receive payouts for cancer on their policies. Just under half (48%) of all male claims for CI are related to cancer, compared to nearly seven out of 10 (65%) of female claims. After cancer the next overall illness claimed for is heart attack (13%), followed by stroke (7%), brain tumour (5%) and total and permanent disability (5%). The average payout per claim is nearly £79,000 while the largest payout by Bupa Individual Protection to date has been £750,00...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Protection

Consumer Duty: Two years on – the protection impact

Consumer Duty: Two years on – the protection impact

Impact on the market and next steps

Jaskeet Briah
clock 01 August 2025 • 5 min read
Alcohol, Britain, one night stands and smartwatches… what does Gen Z really think?

Alcohol, Britain, one night stands and smartwatches… what does Gen Z really think?

'Listening to younger people is as refreshing as it is challenging. But ignoring it isn't an option'

Kevin Carr
clock 24 July 2025 • 4 min read
Group life cover excluded from IHT liability

Group life cover excluded from IHT liability

HMRC decision on protection and inheritance tax

Cameron Roberts
clock 23 July 2025 • 2 min read